Optimizing Biological Processes

By providing a dynamic perspective on cellular behavior and interactions at scale, Temporal Cytomery opens up new avenues for research across diverse applications.

Fundamental Biological Research

Explore the Unexplored

Pose new research questions, explore uncharted territories in cell biology, and advance fundamental research by decoding complex cellular mechanisms and interactions.

Go Beyond Snapshot Data

Watch the full story unfold with temporal single-cell analysis at scale. Understand the 'why' and 'how' behind biological processes by moving beyond static snapshots to a dynamic view of cellular behavior.

Bio-Production & Foodtech

Process Optimization

Temporal Cytometry provides a detailed view of cell line morphology and metabolic dynamics, enabling data driven process optimization

Real-time Cell Line Monitoring

Continuously track your cell lines' health and productivity, ensuring stability and minimizing the risk of batch failures for unparalleled operational efficiency.

Drug Development

Identify Mechanism of Action

Understand causality and mechanism of action

Predict Resistance

Identify escape variants to reveal the cellular response to drugs over time and predict resistance patterns.

Patient Stratification for Clinical Trials

Predict individual treatment response based on functional analysis of responses, paving the way for personalized medicine.

Testimonials

Hear from scientists, researchers, and industry leaders.

"TeraCyte has developed unique, high throughput, single cell analysis technology, important in industry, medicine, and research.  Applications in industry are underway, impactful across the entire range from drug development to production.

Noble Laureate                                     Roger D. Kornberg

Noble Laureate                                     Roger D. Kornberg

TeraCyte Advisor

Professor - Stanford Medical School

“TeraCyte’s solution will enable accurate, quantitative computational models that allow one to predict how cells will respond to novel drugs and other perturbations”

Michael B. Elowitz

Michael B. Elowitz

TeraCyte Advisor and Collaborator

CALTECH Professor of Biology, Bioengineering and Applied Physics, Bren Scholar; Investigator, Howard Hughes Medical Institute One of the founders of Synthetic Biology

“With TeraCyte you can follow each cell individually. We are cooperating with them to tackle a scientific question that currently only their system will be able to answer”

Taken from "The Marker" article
Avidor Shulman, Ph.D,

Avidor Shulman, Ph.D,

TeraCyte Collaborator

Biond Biologics LTD. Biond’s CTO since its inception.Previously Senior Director of Protein Chemistry at Protalix Biotherapeutics (NASDAQ: PLX)

“TeraCyte ability to collect high throughput dynamical data at the single cell level will revolutionize our quantitative understanding of information processing in cells, leading to new approaches for personalized diagnostic and treatment.

Galit Lahav

Galit Lahav

TeraCyte Advisor and Collaborator

Department Chair Systems Biology at Harvard Medical School

TeraCyte has developed unique, high throughput, single cell analysis technology, important in industry, medicine, and research.  Applications in industry are underway, impactful across the entire range from drug development to production.

Noble Luariate                                     Roger D. Kornberg

Noble Luariate                                     Roger D. Kornberg

TeraCyte Advisor

Professor - Stanford Medical School

“TeraCyte’s solution will enable accurate, quantitative computational models that allow one to predict how cells will respond to novel drugs and other perturbations”

Michael B. Elowitz

Michael B. Elowitz

TeraCyte Advisor and Collaborator

CALTECH Professor of Biology, Bioengineering and Applied Physics, Bren Scholar; Investigator, Howard Hughes Medical Institute One of the founders of Synthetic Biology

“With TeraCyte you can follow each cell individually. We are cooperating with them to tackle a scientific question that currently only their system will be able to answer”

Taken from "The Marker" article
Avidor Shulman, Ph.D,

Avidor Shulman, Ph.D,

TeraCyte Collaborator

Biond Biologics LTD.
Biond’s CTO since its inception.
Previously Senior Director of Protein Chemistry at Protalix Biotherapeutics (NASDAQ: PLX)

“TeraCyte ability to collect high throughput dynamical data at the single cell level will revolutionize our quantitative understanding of information processing in cells, leading to new approaches for personalized diagnostic and treatment.”

Galit Lahav

Galit Lahav

TeraCyte Advisor and Collaborator

Department Chair Systems Biology at Harvard Medical School

arrow right
arrow right

Explore The Possibilities

What groundbreaking hypothesis can you test with the data unlocked by Temporal Cytomery? 
Let's explore the possibilities together. Connect with us to learn more.

Contact us